Predicted protein targets (top 16)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | LMNA | P02545 | 2/20 | 0.39 |
| ▸ | APOBEC3A | P31941 | 1/20 | 0.39 |
| ▸ | APOBEC3G | Q9HC16 | 1/20 | 0.39 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.36 |
| ▸ | CES2 | O00748 | 3/20 | 0.36 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.33 |
| ▸ | NAAA | Q02083 | 2/20 | 0.32 |
| ▸ | FAAH | O00519 | 1/20 | 0.32 |
| ▸ | L3MBTL1 | Q9Y468 | 2/20 | 0.32 |
| ▸ | BBOX1 | O75936 | 2/20 | 0.32 |
| ▸ | CES1 | P23141 | 2/20 | 0.31 |
| ▸ | TSHR | P16473 | 2/20 | 0.31 |
| ▸ | MEN1 | O00255 | 1/20 | 0.31 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.31 |
| ▸ | PTGS2 | P35354 | 1/20 | 0.30 |
| ▸ | AKR1B1 | P15121 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL16701182 | 0.98 | LMNA (0.41) | LMNAAPOBEC3AAPOBEC3GALDH1A1CES2 | |
| SCHEMBL16700361 | 0.94 | ALDH1A1 (0.38) | LMNAAPOBEC3AAPOBEC3GALDH1A1CES2 | |
| SCHEMBL15820187 | 0.86 | LMNA (0.35) | LMNAAPOBEC3AAPOBEC3GALDH1A1BBOX1 | |
| SCHEMBL10551152 | 0.85 | LMNA (0.38) | LMNAAPOBEC3AAPOBEC3GALDH1A1KMT2A | |
| SCHEMBL5801688 | 0.83 | CDC25A (0.40) | LMNAAPOBEC3AAPOBEC3GCES2 | |
| SCHEMBL16569932 | 0.82 | LMNA (0.37) | LMNAAPOBEC3AAPOBEC3GCES2KMT2A | |
| SCHEMBL1695937 | 0.81 | LMNA (0.46) | LMNAALDH1A1CES2KMT2ANAAA | |
| SCHEMBL16700592 | 0.78 | FAAH (0.40) | CES2KMT2AFAAHCES1MEN1 | |
| SCHEMBL15209391 | 0.77 | ALDH1A1 (0.33) | ALDH1A1CES2KMT2AMEN1 | |
| SCHEMBL16701138 | 0.74 | FAAH (0.35) | CES2KMT2AFAAHCES1MEN1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20150335547-A1 | ORAL CARE COMPOSITION CONTAINING IONIC LIQUIDS | COLGATE-PALMOLIVE COMPANY (US) | 2015-11-26 | — | — | US | disclosed |
| EP-2934469-A2 | ORAL CARE COMPOSITION CONTAINING IONIC LIQUIDS | Colgate-Palmolive Company (US) | 2015-10-28 | — | — | EP | disclosed |
| WO-2014098871-A2 | ORAL CARE COMPOSITION CONTAINING IONIC LIQUIDS | COLGATE-PALMOLIVE COMPANY (US) | 2014-06-26 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20150335547-A1 | ORAL CARE COMPOSITION CONTAINING IONIC LIQUIDS | MCOLN3, TAS2R39, TAS2R40 | LMNA 1795/4885APOBEC3A 4021/4885APOBEC3G 3658/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.